Sco1389 synthesizes CL using CDP-DAG as a substrate. A, expression of the Cls Sco1389 in the CL-deficient R. etli mutant CFNX185. Lipids of R. etli strains were radiolabeled with [14C]acetate during growth in complex medium, separated by one-dimensional TLC, and visualized by autoradiography. The following strains were analyzed: CL-deficient R. etli mutant CFNX185 (lane 1), CFNX185.pMSC03 (empty vector, lane 2), CFNX185.pMSC04 (Sco1389-expressing, lane 3), R. etli wild-type CE3 (lane 4). B, in vitro assays for the transfer of [32P]phosphatidate from [32P]CDP-DAG into CL. Autoradiography of a TLC of lipid products obtained from Cls enzymatic assays using membrane extracts of different R. etli strains. Cls activity assays were performed with membrane extracts of the strains CFNX185.pMSC04 (lanes 1, 2, and 5), CFNX185 (lane 3), and R. etli wild-type CE3 (lane 4) were incubated with 50 μm [32P]CDP-DAG, 50 μm PG, 0.05% Triton X-100 and 10 mm CoSO4 or MnSO4, 20 mm EDTA were added when indicated. CL was identified with commercial standards. CL, cardiolipin; PG, phosphatidylglycerol; PE, phosphatidylethanolamine; MMPE, monomethyl phosphatidylethanolamine; DMPE, dimethyl phosphatidylethanolamine; and PC, phosphatidylcholine.